A
    Alenvo

    Terms of Service

    Last updated: February 2025

    1. Acceptance of Terms

    By accessing and using Alenvo ("the Platform"), you agree to be bound by these Terms of Service. If you do not agree to these terms, please do not use our Platform.

    2. Description of Service

    Alenvo provides an IND (Investigational New Drug) readiness assessment tool designed for biotech and pharmaceutical regulatory teams. The Platform offers structured questionnaires, scoring algorithms, and risk visualization tools.

    3. Use of the Platform

    You agree to:

    • Use the Platform only for lawful purposes
    • Provide accurate information in your assessments
    • Not attempt to reverse engineer or copy the Platform
    • Not use the Platform to transmit harmful or malicious content

    4. Intellectual Property

    All content, features, and functionality of the Platform, including but not limited to the assessment framework, scoring algorithms, and user interface, are owned by Alenvo and are protected by international copyright and trademark laws.

    5. Disclaimer of Warranties

    The Platform is provided "as is" without warranties of any kind. Alenvo does not guarantee that the Platform will be uninterrupted, secure, or error-free. The assessment results are for informational purposes only and should not replace professional regulatory advice.

    6. Limitation of Liability

    Alenvo shall not be liable for any indirect, incidental, special, consequential, or punitive damages arising from your use of the Platform. This includes any decisions made based on assessment results.

    7. Regulatory Guidance Disclaimer

    Alenvo is a decision-support tool and does not provide regulatory advice. Users should consult qualified regulatory affairs professionals and relevant regulatory agencies for official guidance on IND submissions.

    8. Changes to Terms

    We reserve the right to modify these Terms at any time. We will notify users of significant changes. Continued use of the Platform after changes constitutes acceptance of the new Terms.

    9. Contact Information

    For questions about these Terms, please contact us at legal@alenvo.com.